T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.453
-0.009 (-1.93%)
Nov 21, 2024, 10:55 AM EST - Market open

T2 Biosystems Stock Forecast

TTOO's stock price has decreased by -88.16% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for T2 Biosystems stock has a target of 5.00, which predicts an increase of 1,004.00% from the current stock price of 0.45.

Analyst Consensus: Hold
Target Low Average Median High
Price $5.00 $5.00 $5.00 $5.00
Change +1004.0% +1004.0% +1004.0% +1004.0%
* Price targets were last updated on Jul 30, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for T2 Biosystems is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 000000
Buy 000000
Hold 211111
Sell 000000
Strong Sell 000000
Total 211111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$3$5
Hold Maintains $3$5 +1,004.00% Jul 30, 2024
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$12$3
Hold Maintains $12$3 +562.40% Apr 29, 2024
Alliance Global Partners
Alliance Global Partners
Hold
Maintains
$12$7
Hold Maintains $12$7 +1,445.60% Jul 13, 2023
Alliance Global Partners
Alliance Global Partners
Hold
Maintains
$220$150
Hold Maintains $220$150 +33,019.89% Jan 24, 2023
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
$1,250$250
Hold Downgrades $1,250$250 +55,099.82% Oct 14, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
10.81M
from 7.19M
Increased by 50.31%
Revenue Next Year
23.56M
from 10.81M
Increased by 117.92%
EPS This Year
-3.16
from -19.19
EPS Next Year
-1.21
from -3.16
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
8.34M18.13M28.06M22.31M7.19M10.81M23.56M33.97M
Revenue Growth
-20.62%117.52%54.76%-20.50%-67.75%50.31%117.92%44.16%
EPS
--1,928.54-1,549.82-1,222.14-19.19-3.16-1.21-0.71
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 11.1M 24.3M 35.0M
Avg 10.8M 23.6M 34.0M
Low 10.4M 22.6M 32.6M

Revenue Growth

Revenue Growth 20242025202620272028
High
54.7%
124.3%
48.4%
Avg
50.3%
117.9%
44.2%
Low
44.4%
109.4%
38.5%

EPS Forecast

EPS 20242025202620272028
High -3.26 -1.25 -0.74
Avg -3.16 -1.21 -0.71
Low -3.04 -1.17 -0.69

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.